Publicação
Targeted therapies for lung cancer: how did the game begin?
| dc.contributor.author | Kanellakis, NI | |
| dc.contributor.author | Jacinto, T | |
| dc.contributor.author | Psallidas, I | |
| dc.date.accessioned | 2017-01-12T22:46:04Z | |
| dc.date.available | 2017-01-12T22:46:04Z | |
| dc.date.issued | 2016-06 | |
| dc.description.abstract | Landmark studies on genetic alterations underlying NSCLC have led to tailored therapies http://ow.ly/4nq0Ps. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Breathe (Sheff). 2016 Jun;12(2):177-9. | pt_PT |
| dc.identifier.doi | 10.1183/20734735.006316 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.26/17486 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | Neoplasias do Pulmão | pt_PT |
| dc.subject | Lung Neoplasms | pt_PT |
| dc.title | Targeted therapies for lung cancer: how did the game begin? | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 179 | pt_PT |
| oaire.citation.issue | 2 | pt_PT |
| oaire.citation.startPage | 177-9 | pt_PT |
| oaire.citation.volume | 12 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |